Speaker illustration

Miss Elissa Polomski

Leiden University Medical Center, Leiden (Netherlands (The))

Patients with non-Hodgkin's lymphoma treated with CAR T-cell therapy are at risk of impaired left ventricular function

Event: Heart Failure 2024

Topic: Cardio-Oncology

Session: Cardiovascular disease in special populations - cardio-oncology (1)

Thumbnail

Relation between coronary artery calcium score and cardiovascular events in Hodgkin lymphoma survivors: a cross-sectional matched cohort study

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: Imaging in cardio-oncology

Thumbnail

Arterial inflammation induced by immune checkpoint inhibitors assessed on 18F-FDG PET-CT scans in stage III/IV melanoma patients

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: T-cells, checkpoint inhibitors, and cardiac complications

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb